← Back to Search

Neurofeedback for Alcohol Use Disorder

N/A
Waitlist Available
Led By Reza Momenan, Ph.D.
Research Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stage 2: Inpatient currently seeking treatment for alcohol use disorder
Stage 1: 21 to 65 years old
Must not have
History of neurological disease based on self-report and neuromotor physical exam, conducted by a health care provider, that would interfere with neuroimaging research. Posthoc, clinical MRI scans done according to NIH Clinical Center policy may be reviewed and if there is evidence from that scan of past or current neuroabnormalities that, in the PI or MAI s expert opinion, interfere with research neuroimaging data, the subject may be excluded from data analysis.
Female participants only: Currently pregnant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3, 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if neurofeedback, a technique where people see their own brain activity, can help people with problem drinking.

Who is the study for?
Adults aged 21-65 with moderate to severe alcohol use disorder (AUD) and healthy volunteers who drink minimally are eligible. AUD participants must be diagnosed according to SCID 5 criteria and may include inpatients seeking treatment for AUD. Healthy individuals should consume less than 7 drinks/week for females, or 14 drinks/week for males.
What is being tested?
The trial is testing real-time fMRI neurofeedback to understand brain activity related to socioemotional processing in people with AUD when exposed to social and alcohol-related images, aiming to see if controlling this activity can help treat problem drinking.
What are the potential side effects?
There are no direct side effects from the fMRI neurofeedback itself mentioned, but being in an MRI scanner involves lying still in a confined space which might cause discomfort or anxiety for some people.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am in the hospital seeking treatment for alcohol use.
Select...
I am between 21 and 65 years old.
Select...
I have been diagnosed with a moderate to severe alcohol use disorder.
Select...
I am between 21 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any neurological conditions that would affect brain imaging studies.
Select...
I am currently pregnant.
Select...
I have had major head injuries or brain surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol Attention Bias
Alcohol Craving
Secondary study objectives
Alcohol consumption
Antisocial behavior
Community functioning

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stage 2Experimental Treatment1 Intervention
Main Clinical Trial with random assignment
Group II: Stage 1Active Control1 Intervention
Pilot portion to optimize intervention and achievecorrelational research aims

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Lead Sponsor
835 Previous Clinical Trials
1,082,676 Total Patients Enrolled
Reza Momenan, Ph.D.Principal InvestigatorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)
9 Previous Clinical Trials
5,091 Total Patients Enrolled

Media Library

Real time fMRI neurofeedback Clinical Trial Eligibility Overview. Trial Name: NCT03535129 — N/A
Alcohol Use Disorder Research Study Groups: Stage 1, Stage 2
Alcohol Use Disorder Clinical Trial 2023: Real time fMRI neurofeedback Highlights & Side Effects. Trial Name: NCT03535129 — N/A
Real time fMRI neurofeedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT03535129 — N/A
~7 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top